Insmed Reports Third-Quarter 2023 Financial Results and Provides Business Update ...Middle East

PR Newswire - News
Insmed Reports Third-Quarter 2023 Financial Results and Provides Business Update
—ARIKAYCE® (amikacin liposome inhalation suspension) Total Revenue of $79.1 Million for the Third Quarter of 2023 Reflects Highest Quarter of Sales Since Launch and 17% Growth Compared to the Third Quarter of 2022— —Company Reiterates Full-Year 2023 Guidance Range for Global ARIKAYCE...

Hence then, the article about insmed reports third quarter 2023 financial results and provides business update was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Insmed Reports Third-Quarter 2023 Financial Results and Provides Business Update )

Apple Storegoogle play

Last updated :

Also on site :